Synergistic Transcutaneous Immunotherapy Enhances Antitumor Immune Responses through Delivery of Checkpoint Inhibitors-Reference-Cited by-全球学者库

Synergistic Transcutaneous Immunotherapy Enhances Antitumor Immune Responses through Delivery of Checkpoint Inhibitors

Published:2016-09-06 Issue:9 Volume:10 Page:8956-8963
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Ye Yanqi¹²,Wang Jinqiang¹²,Hu Quanyin¹²,Hochu Gabrielle M.¹,Xin Hongliang¹,Wang Chao¹²,Gu Zhen¹²³

Affiliation:

1. Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, North Carolina 27695, United States

2. Molecular Pharmaceutics Division and Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

3. Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, United States

Funder

National Center for Advancing Translational Sciences

University of North Carolina

North Carolina Translational and Clinical Sciences, University of North Carolina

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.6b04989

Reference43 articles.

1. Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

2. Engineered materials for cancer immunotherapy

3. Engineering opportunities in cancer immunotherapy

4. Biomaterials for enhancing anti-cancer immunity

5. The future of immune checkpoint therapy

Cited by 277 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and validation of an individualized metabolic prognostic signature for predicting the biochemical recurrence of prostate cancer based on the immune microenvironment;European Journal of Medical Research;2024-01-31

2. Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer;International Journal of Molecular Sciences;2024-01-18

3. Nanoparticle-integrated dissolving microneedles for the co-delivery of R848/aPD-1 to synergistically reverse the immunosuppressive microenvironment of triple-negative breast cancer;Acta Biomaterialia;2024-01

4. Novel technologies for applying immune checkpoint blockers;International Review of Cell and Molecular Biology;2024

5. Recent progress in cancer immunotherapy: Application of nano-therapeutic systems;Journal of Drug Delivery Science and Technology;2024-01